中国365bet中文官网

WASHINGTON, April 9, 2019 鈥� The American Chemical 中国365bet中文官网 (ACS) today announced Fr茅d茅rique Cunin, Ph.D., as the winner of the 2019 Franco-American Lectureship Prize. The prize honors chemists and chemical engineers who have contributed significantly to research cooperation between the United States and France.

Cunin is a materials science researcher at the Institut Charles Gerhardt Montpellier in Montpellier, France, where she focuses on the development and fundamental properties of porous silicon particles. In particular, her research has applications in nanomedicine, targeted anti-cancer therapies, gene-based therapies and tissue engineering. Cunin has long-established ties to the U.S. research community, including spending time as a postdoctoral researcher in the laboratory of Michael Sailor, Ph.D. of the University of California, San Diego. She has worked extensively to build bridges between French and American chemistry practitioners and has served as an organizer for several cross-cultural research conferences. Notably, Cunin served as a co-principal investigator on a joint National Science Foundation/Centre national de la recherche scientifique grant, Materials World Network: Cooperative Activity in Materials Research Between US Investigators and their Counterparts Abroad.

The Franco-American Lectureship Prize is a joint endeavor between ACS and the French Chemical 中国365bet中文官网 (SCF), awarded on a rotating basis to an American or French chemist. This year, the French recipient was selected by the ACS Committee on International Activities, with the SCF selecting an American chemist next year. As part of her prize, Cunin will conduct a lecture tour later in 2019 at ACS local sections and universities in the U.S.

鈥淚鈥檓 very honored to receive the ACS/SCF lectureship prize, for the opportunity to deliver lectures and to meet with incredible scientists,鈥� Cunin says. 鈥淪ince the beginning of my career, I have enjoyed fostering collaboration and exchange between our two countries, and I look forward to touring across the U.S.鈥�